AquaBounty Technologies, Inc. (AQB)
1.35
+0.06
(+4.65%)
USD |
NASDAQ |
Aug 27, 15:31
AquaBounty Technologies Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | -1.788 |
| December 31, 2025 | -1.856 |
| September 30, 2025 | 0.6488 |
| June 30, 2025 | 0.6276 |
| March 31, 2025 | 0.067 |
| September 30, 2024 | 0.057 |
| June 30, 2024 | 0.1041 |
| March 31, 2024 | 0.0559 |
| December 31, 2023 | 0.0533 |
| September 30, 2023 | 0.0504 |
| June 30, 2023 | 0.0505 |
| March 31, 2023 | 0.0491 |
| December 31, 2022 | 0.0464 |
| September 30, 2022 | 0.0433 |
| June 30, 2022 | 0.0445 |
| March 31, 2022 | 0.0448 |
| December 31, 2021 | 0.0442 |
| September 30, 2021 | 0.0437 |
| June 30, 2021 | 0.0423 |
| March 31, 2021 | 0.0403 |
| December 31, 2020 | 0.0796 |
| September 30, 2020 | 0.1529 |
| June 30, 2020 | 0.1557 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.131 |
| December 31, 2019 | 0.2109 |
| September 30, 2019 | 0.1851 |
| June 30, 2019 | 0.1706 |
| March 31, 2019 | 0.1635 |
| December 31, 2018 | 0.1546 |
| September 30, 2018 | 0.1408 |
| June 30, 2018 | 0.1241 |
| March 31, 2018 | 0.1162 |
| December 31, 2017 | 0.1715 |
| September 30, 2017 | 0.1514 |
| June 30, 2017 | 0.131 |
| March 31, 2017 | 0.1124 |
| December 31, 2016 | 1.313 |
| September 30, 2016 | -1.705 |
| June 30, 2016 | -1.839 |
| March 31, 2016 | |
| December 31, 2015 | -37.24 |
| September 30, 2015 | |
| December 31, 2014 | 0.6901 |
| September 30, 2014 | 0.5026 |
| June 30, 2014 | 0.3823 |
| March 31, 2014 | 0.2767 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Agenus, Inc. | -1.458 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 11.71M |
| Total Liabilities (Quarterly) | 8.897M |
| Shareholders Equity (Quarterly) | 2.812M |
| Current Ratio | 4.256 |
| Net Debt Paydown Yield | 4.13% |